Disclosure Panels Details Page
B-Cell Lymphomas Panel - Disclosures as of 06/30/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jeremy Abramson MD,MMSc | AbbVie, Inc. BeiGene Bristol Myers Squibb Cellectis Genentech, Inc. MEI Pharma Inc. Merck & Co., Inc. Mustang bio Regeneron Pharmactcls |
AbbVie, Inc. ADC Therapeutics AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Genentech, Inc. Gilead Sciences, Inc. Interius Novartis Pharmaceuticals Corporation SeaGen |
None | None | 04/01/2024 |
| Ranjana Advani MD | ADC Therapeutics Autolus BeiGene Daiichi- Sankyo Co. Genentech/Roche Gilead Sciences, Inc. Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. Roche |
ADC Therapeutics Autolus BeiGene Genentech, Inc. Roche |
None | None | 06/27/2024 |
| Babis Andreadis MSCE,MD | Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. GenMab Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Gilead Sciences, Inc. Pharmacyclics |
None | None | 02/12/2024 |
| Nancy Bartlett MD | ADC Therapeutics Autolus BMS/Celgene Forty Seven, Inc. Gilead/Kite Pharma Janssen Pharmaceutica Products, LP Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Pharmacyclics Roche/Genentech SeaGen |
Foresight Diagnostics Genmab/AbbVie Kite Pharma Roche/Genentech |
None | Foresight Diagnostics|Genmab/AbbVie|Kite Pharma|Roche/Genentech | 01/08/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Lihua Budde MD,PhD | AstraZeneca Pharmaceuticals LP Genentech, Inc. Kite Pharma Merck & Co., Inc. |
AbbVie, Inc. ADC Therapeutics AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Roche Laboratories, Inc. |
None | None | 03/07/2024 |
| Paolo Caimi MD | ADC Therapeutics Genentech, Inc. GenMab Kite Pharma Luminary Therapeutics Mustang biotech Synthekine |
Bristol Myers Squibb Genentech, Inc. Novartis Pharmaceuticals Corporation |
Arvinas Recordati SOBI |
None | 12/21/2023 |
| Julie Chang MD | None | AbbVie, Inc. BeiGene Genentech, Inc. ONO Pharmaceuticals |
Forefront Collaborative | None | 06/18/2024 |
| Beth Christian MD | Acerta Pharma Bristol Myers Squibb Genentech, Inc. Millennium Pharmaceuticals, Inc. |
AstraZeneca Pharmaceuticals LP Ipsen |
None | None | 05/09/2024 |
| Sven DeVos PhD,MD | None | None | None | None | 04/15/2024 |
| Bhagirathbhai Dholaria MD | Adicet AstraZeneca Pharmaceuticals LP Atara Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP MEI Orca Bio Poseida Takeda Pharmaceuticals North America, Inc. Wugen |
Acrotec ADC therapeutics Autolus Boxter Capital Ellipsis pharma Janssen Pharmaceutica Products, LP Luminity MJH bio Pluri Bio |
Gilead Sciences, Inc. | None | 04/02/2024 |
| Mary Dwyer MS | None | None | None | None | 05/29/2024 |
| Meghan Fay OCN,RN,BSN | None | None | None | None | 05/28/2024 |
| Luis Fayad MD | EUSA Genentech, Inc. Medicamenta Pharmacyclics Roche Laboratories, Inc. |
EUSA | None | None | 03/06/2024 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 04/22/2024 |
| Leo Gordon MD | Zylem Biosciences | Novartis Pharmaceuticals Corporation Ono Pharmaceuticals |
None | None | 06/23/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 05/27/2024 |
| Thomas Habermann MD | Celgene Corporation Eli Lilly and Company Genentech, Inc. Pfizer Inc. Sorrento Tess Therapeutics |
BeiGene Genentech, Inc. Incyte Corporation Janssen Pharmaceutica Products, LP Loxo Oncology MorphoSys AG |
None | None | 03/06/2024 |
| Muhammad Saad Hamid MD | None | None | None | None | 03/08/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 06/18/2024 |
| Laura Hanisch PsyD | None | None | None | None | 06/12/2024 |
| Francisco Hernandez-Ilizaliturri MD | None | AbbVie, Inc. Amgen Inc. BeiGene Bristol Myers Squibb Celgene Corporation Cellectar Epizyme Incyte Corporation Ipsen Kite Pharma Novartis Pharmaceuticals Corporation |
None | None | 02/17/2024 |
| Erin Hesler | None | None | None | None | 05/08/2024 |
| Boyu Hu MD | Artiva Biotherapeutics AstraZeneca Pharmaceuticals LP Caribou Biosciences Celgene Corporation CRISPR Therapeutics Genentech, Inc. ImmPACT Bio MorphoSys AG Newave Repare Therapeutics |
AbbVie, Inc. ADC Therapeutics Caribou Biosciences ImmPACT Bio Regeneron Pharmactcls SeaGen |
DAVA Oncology | None | 02/25/2024 |
| Yasmin Karimi MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Eli Lilly and Company Genentech, Inc. GenMab Gilead Sciences, Inc. Merck & Co., Inc. Pfizer Inc. Roche Laboratories, Inc. Xencor |
AbbVie, Inc. ADC therapeutics |
Genentech, Inc. RMEI medical education Roche Laboratories, Inc. |
None | 06/19/2024 |
| Ann Karosas BCOP,RPh | None | None | None | None | 02/26/2024 |
| Christopher Kelsey MD | Galera Therapeutics | Colgate-Palmolive Johnson & Johnson |
None | None | 02/27/2024 |
| Rebecca King MD | None | None | None | Wolters Kluver Health publishing company | 04/08/2024 |
| Justin Kline MD | None | AbbVie, Inc. ADC Therapeutics BeiGene Curio Science Gilead Sciences, Inc. SeaGen |
Targeted Oncology | None | 04/09/2024 |
| Susan Krivacic MPAff | None | None | None | None | 01/08/2024 |
| Ann LaCasce MD,MMSc | None | Kite Pharma | Research to Practice | None | 06/17/2024 |
| Daniel Landsburg MD | Karyopharm Therapeutics | ADCT Calithera Novartis Pharmaceuticals Corporation |
None | None | 02/22/2024 |
| Megan Lim MD | ThermoFisher Inc | Thermo Fisher | None | None | 06/13/2024 |
| Marcus Messmer MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Genentech, Inc. |
None | None | None | 01/15/2024 |
| John Murphy | None | None | None | None | 04/22/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Rachel Rabinovitch MD | None | None | None | None | 03/07/2024 |
| Praveen Ramakrishnan MD,MS | None | ADC Therapeutics CRISPR Therapeutics Ipsen Regeneron Pharmactcls |
None | None | 03/05/2024 |
| Erin Reid MD | ADC Therapeutics Aptose Biosciences EpiCentrx (spouse) Millennium Pharmaceuticals, Inc. |
None | None | None | 10/23/2023 |
| Kenneth Roberts MD | None | None | None | None | 05/27/2024 |
| Hayder Saeed MD | Astex Pharmaceuticals atra Biotherapeutics Bristol Myers Squibb Genmab Innate Pharma SecuraBio Teneo Two |
Acrotech Incyte Corporation MorphoSys AG |
SeaGen | None | 04/14/2024 |
| Naoyuki Saito MD,PhD | None | None | None | None | 02/22/2024 |
| Stephen Smith MD | ADCT Alexion Pharmaceuticals, Inc. AstraZeneca Pharmaceuticals LP Ayala Bayer HealthCare BeiGene Bristol Myers Squibb DeNovo Biopharma Enterome Genentech, Inc. Ignyta Incyte Corporation Kymera Therapeutics Merck & Co., Inc. MorphoSys AG Nanjing Pharmaceuticals Co. Ltd Viracta |
AbbVie, Inc. ADC Therapeutics BeiGene Coherus Genentech, Inc. Incyte Corporation Kite Pharma lumanity numab |
None | None | 02/08/2024 |
| Hema Sundar PhD | None | None | None | None | 04/28/2024 |
| Lode Swinnen MBChB | AbbVie, Inc. | ADC therapeutics | None | Johns Hopkins University | 03/06/2024 |
| Joseph Tuscano MD | AbbVie, Inc. ADC therapeutics Bristol Myers Squibb Genentech, Inc. Pharmacyclics SeaGen Takeda Pharmaceuticals North America, Inc. |
ADC therapeutics | None | None | 02/26/2024 |
| Julie Vose MD,MBA | AbbVie, Inc. Bristol Myers Squibb Epizyme Gamidacell Genmab Kite Pharma Lilly Loxo Novartis Pharmaceuticals Corporation SeaGen |
AbbVie, Inc. Adaptive Gamidacell GenMab MEI Pharma Novartis Pharmaceuticals Corporation |
None | None | 04/27/2024 |
| Andrew Zelenetz PhD,MD | AbbVie, Inc. BeiGene Bristol Myers Squibb Genentech, Inc. MEI Pharma Inc. Pharmacyclics Roche Laboratories, Inc. |
AbbVie, Inc. Arvinas AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Curio Science DAVA Oncology Eli Lilly and Company Follicular Lymphoma Foundation Genentech, Inc. Genmab Gilead Sciences, Inc. Ipsen MEI Pharma Inc. |
None | None | 06/28/2024 |